✦ LIBER ✦

Time to rethink clinically important outcomes in platelet transfusion trials

✍ Scribed by Nancy M. Heddle; Donald M. Arnold; Kathryn E. Webert

Book ID: 109146275
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 155 KB
Volume: 51
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2010.02982.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measuring outcomes in clinical trials of

Measuring outcomes in clinical trials of stroke: time for state-of-the-art clinical trials to reject state-of-the-ark rating scales

✍ Jeremy Hobart 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 98 KB

Completion of premaintenance phases in t

Completion of premaintenance phases in total therapies 2 and 3 improves clinical outcomes in multiple myeloma : An important variable to be considered in clinical trial designs

✍ Bart Barlogie; Jeff Haessler; Mauricio Pineda-Roman; Elias Anaissie; Frits van R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

## Abstract ## BACKGROUND. Total Therapy (TT) programs are complex and their execution over the course of several years is fraught with patient attrition due to failure and toxicity of therapy and patient/physician acceptance. ## METHODS. The impact of completion versus noncompletion of intended